DOCTOR INFORMATION
Menopause and HRT
What are the symptoms of the menopauseβ
Hot flushes π°
Night sweats π€
Mood changes (low mood/anxiety)
Difficulty/disturbances sleeping π€
Cognitive disturbances (memory loss/difficulty concentrating)
Libido loss (sex drive)
Irregular menstruation
Dry vagina
Urination problems π§
Aches and pains of joints/muscles
How is the menopause diagnosedβ
- Usually based on the clinical symptoms & age; but beware the following;
- Abnormal bleeding needs investigating
- Consider differential diagnosis
- Arrange Follicle Stimulating Hormone for patients if:
- < 40: premature menopause (2 separate results, > 30 IU/L, between 4 and 8 weeks apart)
- < 45: early menopause (2 separate results, >30 IU/L, between 4 and 8 weeks apart)
- > 50: wants to stop taking hormonal contraception (1 > 30 IU/L result β patient can stop taking hormonal contraception in 12 months)
How is the menopause treatedβ
Lifestyle changes:
Regular exercise π΄
Relaxation exercise
Stress reduction β¬
Decrease alcohol intake
Smoking cessation π¬
Healthy BMI
Improve sleep hygiene π€
Avoid vasomotor symptoms (e.g. spicy food)
HRT (Hormone Replacement Therapy):
Fist line therapy for low mood and vasomotor symptoms
Also beneficial for musculoskeletal symptoms, low sex drive, bone mineral density and urogenital atrophy
HRT alternative options:
CBT β beneficial for low mood and anxiety symptoms π’
Isoflavones β can be beneficial for hot flushes π°
Avoid SSRIs, SNRIs and clonidine as first line therapy
Are there any contraindications to HRTβ
History of breast cancer or oestrogen-rich tumour
Bleeding of vagina which is undiagnosed
Arterial thromboembolic disease
Thrombophillia
Endometrial hyperplasia which is untreated
Current/recurrent VTE
Liver disease
What are the risks of HRTβ
Breast cancer:
Risk from lifestyle choices likely greater than from HRT π¬
Greater risk with combined HRT than oestrogen only HRT
Micronised progesterone likely safest progestogen
VTE:
Risk increased by HRT β¬
Oral HRT preparations increase risk β¬
Micronised progesterone likely safest progestogen
CVD (Cardiovascular disease):
Post-menopausal women most commonly die of CVD
In women <65, HRT does NOT increase risk
HRT may be cardioprotective in younger women
Stroke (CVA):
Oral HRT increases risk (transdermal HRT preparations are safest) β¬
Ovarian Cancer:
Risk slightly increased by HRT β¬
What are the different types of HRTβ
What type of HRT should I offer my patientβ
When should I review menopause treatmentβ
3 months after you start treatment π
Annually thereafter
What should I look for when reviewing a patientβ
- Ask the patient about any side effects, symptoms and indications
- Check patientβs blood pressure, BMI and screening
What if I identify problems when reviewing a patientβ
Heavy bleeding on sequential HRT β increase progestogen dose/duration
Bleeding on combined HRT β if remains after 3 to 6 months of it, try sequential HRT instead
Persistent bleeding more than 6 months after starting HRT β investigate the reason for this
Side effects caused by progestogen β try alternative progestogen or IUS
Summary:
- There are many symptoms of menopause which you should be aware of
- Menopause is usually diagnosed based on clinical symptoms and age
- Treatments: lifestyle changes, HRT or alternatives
- HRT risks: breast cancer, VTE, cardiovascular disease, stroke, ovarian cancer
- There are 3 types of HRT: oestrogen only, sequential combined and continuous combined
- You should review treatment 3 months after starting and annually thereafter